echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Changes in the two sirtuin enzymes can change mitochondrial dynamics and weaken heart contraction

    Changes in the two sirtuin enzymes can change mitochondrial dynamics and weaken heart contraction

    • Last Update: 2021-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Now, a new preclinical study by the University of South Florida Health (Universal Service Fund Health) researchers has determined that sirtuin protein 1 (SIRT1) and sirtuin protein 3 (SIRT3) levels decline, aging the heart, and affect the ability of cardiomyocytes ( Cardiomyocytes) contract against ischemia-reperfusion injury (also called reperfusion injury)


    The results of this study were published in the July 3 issue of "Aging Cells"


    "We found that age-related changes in mitochondrial dynamics are caused by SIRT1/SIRT3 deficiency, especially in cardiomyocytes," said lead researcher Dr.


    In living cells, mitochondria produce the energy needed to drive almost all processes


    Reperfusion is a common treatment after an acute heart attack, which restores blood flow (and thus oxygen) in the area of ​​the heart that has been damaged by a clot blocking the coronary arteries


    To help analyze the response of myocardial mitochondria to ischemia-reperfusion stress, researchers at USF Health deleted SIRT1 or SIRT3 in mouse cardiomyocytes and tested the response of mitochondria to ischemic stress by restricting blood flow


    In addition, when the ischemia-reperfusion stress was introduced, the contraction of the cardiomyocytes of the young mice with SIRT1 or SIRT3 removed was significantly reduced and showed senescence-like cardiac dysfunction


    "We started this study to try to understand why the incidence of heart attacks among older people is higher than that of young people, and why even if they receive maximum treatment, they are more likely to die


    Dr.


    If the results of their mouse model study can be applied to the human heart, Dr.


    "Our ultimate goal is to determine the ideal target for the treatment of heart disease, especially for elderly patients," said Dr.


    Journal Reference :

    1. Jingwen Zhang, Zhibin He, Julia Fedorova, Cole Logan, Lauryn Bates, Kayla Davitt, Van Le, Jiayuan Murphy, Melissa Li, Mingyi Wang, Edward G.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.